Clinical Trial Update: Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis [Phase 4]

View source ↗

Summary

Phase 4 trial assessing sensory attributes of olopatadine 0.6% and azelastine 137 mcg nasal sprays in patients with allergic rhinitis; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Astelin nasal spray (azelastine)
• Patanase nasal spray (olopatadine)

Snippet

Sponsor: Alcon Research | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2010-02-02